Unknown

Dataset Information

0

Vasoactive Peptides: Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets.


ABSTRACT:

Background

The ongoing outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as the latest threat to global health, causes overwhelming effects for the public healthcare systems worldwide. Of note, in addition to the respiratory complications, some patients with coronavirus disease 2019 (COVID-19) also develop serious cardiovascular injuries. Vasoactive peptides play an important role in a wide range of physiological and pathological conditions.

Aim

With the urgent need for exploring the specific therapeutic targets and biomarkers for the emerging COVID-19, the general aim of this review is to discuss the potentials of the vasoactive peptides including Angiotensin II (Ang II), vasoactive intestinal peptide (VIP), endothelin-1 (ET-1), calcitonin gene-related peptide (CGRP), natriuretic peptides, substance P (SP) and bradykinin (BK) as therapeutic targets and/or prognostic indicators for the COVID-19 pandemic.

Conclusion

Based on various observations some authors conclude that the assessment of vasoactive peptides shall be considered a routine part of COVID-19 patient monitoring, and they can serve as potential therapeutic targets for the disease management.

SUBMITTER: Khodabakhsh P 

PROVIDER: S-EPMC8179120 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7994855 | biostudies-literature
| S-EPMC8602358 | biostudies-literature
| S-EPMC8209387 | biostudies-literature
| S-EPMC10346863 | biostudies-literature
| S-EPMC6163343 | biostudies-literature
2010-03-09 | E-GEOD-11482 | biostudies-arrayexpress
| S-EPMC8232221 | biostudies-literature
| S-EPMC8551858 | biostudies-literature
| S-EPMC10378777 | biostudies-literature
| S-EPMC9016159 | biostudies-literature